Healius Limited

ASX (AUD): Healius Limited (HLS)

Last Price

0.935

Today's Change

+0.10 (11.97%)

Day's Change

0.835 - 0.935

Trading Volume

38,175,265

Profile
HLS

Exchange:  Australian Securities Exchange Australian Securities Exchange

Currency:  AUD AUD

Sector:  Healthcare - Healthcare Healthcare - Healthcare

Industry: 

CEO:  Paul D. Anderson Paul D. Anderson

Full Time Employees:  4,329 4,329

IPO Date:  1998-08-03 1998-08-03

CIK: 

ISIN:  AU0000033359 AU0000033359

CUSIP:  Q4548G107 Q4548G107

Beta:  0.39 0.39

Last Dividend:  0.63 0.63

Dcf Diff:  -13.77 -13.77

Dcf:  15.61 15.61

Description

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.

Address

Liberty Place,
Sydney, NSW 2000, AU

61 2 9432 9400

http://www.healius.com.au

Discussions
Be the first to like this. Showing 0 of 0 comments

{uid}

{comment}

Just now

Post a Comment